HNST
The Honest Company, Inc.
HNST has slightly lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has a slight edge over HNST overall, supported by stronger fundamentals and stronger modeled upside.
HNST Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Strong | |
| Strong |
HNST's cash flow and balance sheet are currently strong, and its profitability is stable, but its revenue is under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HNST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 7x | $4.80 | — |
| Cheap | 41x | $28.21 | +488% |
| Fair | 45x | $31.17 | +549% |
| Forward | 60x | $4.80 | — |
| Expensive | 78x | $53.97 | +1024% |
Historical ranges are pointers, not guarantees.
HNST's PE is 7.0x, but its earnings don't support one, so it isn't a reliable read right now.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
HNST Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect HNST's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HNST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.08 | -88% |
| Q3 2026 | $0.69 | +1050% |
| Q2 2026 | -$0.11 | -320% |
| Q1 2026 | -$0.17 | -$0.15 |
| Q4 2025 | -$0.14 | -$0.08 |
| Q3 2025 | $0.06 | +$0.10 |
| Q2 2025 | $0.05 | +$0.18 |
| Q1 2025 | -$0.02 | +$0.21 |
| Q4 2024 | -$0.06 | +$0.36 |
HNST has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
HNST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $84.6M | -8.6% |
| Q2 2026 | $83.3M | -11% |
| Q1 2026 | $78.1M | -20% |
| Q4 2025 | $88M | -12% |
| Q3 2025 | $92.6M | -6.7% |
| Q2 2025 | $93.5M | +0.4% |
| Q1 2025 | $97.3M | +13% |
| Q4 2024 | $99.8M | +11% |
HNST's revenue has slid since its 2024 peak: $85M last quarter, down 8.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.4% | +1 points |
| Q2 2026 | 12% | +8.4 points |
| Q1 2026 | -0.8% | -3.4 points |
| Q4 2025 | -27% | -26 points |
| Q3 2025 | 0.3% | +0.3 points |
| Q2 2025 | 3.1% | +7.4 points |
| Q1 2025 | 2.6% | +4.1 points |
| Q4 2024 | -1% | -2.3 points |
HNST has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over HNST on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
HNST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.8M | -$4.1M |
| Q2 2026 | $31.5M | +$32.3M |
| Q1 2026 | $3.8M | +$6.8M |
| Q4 2025 | $18.1M | +$35.2M |
| Q3 2025 | -$624K | -104% |
| Q2 2025 | -$826K | -128% |
| Q1 2025 | -$3M | -1254% |
| Q4 2024 | -$17.2M | -278% |
HNST has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
HNST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -9.4x | Net Cash |
| Q2 2025 | -9.9x | Net Cash |
| Q1 2025 | -218.7x | Net Cash |
HNST has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HNST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 34.6 | Neutral |
HNST's weekly RSI is 54 (neutral) and its Stochastic is 35 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
HNST PE vs Consumer Cyclical Sector
| Metric | HNST | Sector median | Relative |
|---|---|---|---|
| PE | 7x | 18x | 61% below |
| PE % | 3 | 53 | 50 pts below |
HNST is trading at 7.0x earnings, a 61% discount to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
HNST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.87 | 1.4% below |
| 20 week MA | $4.79 | 0.2% above |
| 50 week MA | $3.69 | 30% above |
| 100 week MA | $4.19 | 15% above |
| 200 week MA | $3.54 | 36% above |
HNST has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
HNST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $19.1 | $8.07 | -58% |
| 2022 | $8.07 | $2.97 | -63% |
| 2023 | $2.97 | $3.30 | +11% |
| 2024 | $3.30 | $6.93 | +110% |
| 2025 | $6.93 | $2.71 | -61% |
| 2026 YTD | $2.71 | $4.80 | +77% |
HNST has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.